It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: ColoradoTemplar
a reply to: NHow1982
Yep. He will probably threaten to take us out behind the gym and teach us a lesson.
originally posted by: americanbuffalo1
a reply to: ColoradoTemplar
Well he did say he was losing his patience. Maybe he will suffer an aneurysm due to this wrench in his works.
originally posted by: ColoradoTemplar
So maybe finally there are a few people in the FDA that are seeing the data and having 2nd doubts about the vaccine all together:
thehill.com...
A federal advisory panel said Friday the Food and Drug Administration (FDA) should not approve a third booster dose of Pfizer and BioNTech's COVID-19 vaccine for everyone 16 or older, but indicated they would be open to boosters for older people.
The panel voted overwhelmingly against the recommendation, 16 to 2.
Friday's vote from the FDA's vaccine advisory committee deals a major blow to the Biden administration's plan to administer booster doses beginning Sept. 20.
Lets see what Biden has to say now.
originally posted by: MiddleInsite
It's interesting that the FDA all of a sudden has credibility, when clearly to many here, it did not.
I always find it funny that with most here, that when you agree with the ruling/finding/decision, well then we can trust it. Otherwise, they are a bunch of government hacks.
I don't see how you can not trust them, and in a split second, you can.
Do you see how ridiculous that is?
So you are saying you trust the FDA and the info they distribute to the public?
a reply to: ColoradoTemplar
originally posted by: ColoradoTemplar
Yep. He will probably threaten to take us out behind the gym and teach us a lesson.
Would be nice to have seen what their recommendation would have been on the vaccine originally, but the FDA did not ask them then.
This authorization of a third dose for immunocompromised individuals is separate and distinct from the booster dose reviewed by VRBPAC today. The third dose for immunocompromised individuals is meant to address the fact that these individuals sometimes do not build enough protection after two doses of the vaccine. In contrast, the booster dose recommended today by VRBPAC for EUA refers to an additional dose of the vaccine that is given to those who have built enough protection after the primary two-dose vaccination series, but may have decreased protection over time due to waning of immunity.